BioStable
About BioStable
BioStable is a cardiovascular device company that develops innovative new products for the treatment of cardiovascular diseases. The company is led by an experienced group of industry executives with expertise in rapid and effective medical device development. The organization incorporates core strengths in all areas of product development including quality systems, design, engineering, prototyping and pilot production, in-vitro and in-vivo testing, manufacturing, global regulatory relationships, clinical product validation, market launch, and distribution. BioStable provides a competitive edge by minimizing time to market for cost-effective medical devices that deliver improved clinical outcomes. The company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. BioStable was founded in
Company Metrics
- Employees: 10-Jan
- Monthly Visits: None
- Tech Stack: 17 active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 10750000 USD
- Last Funding: None (Series C)
- Funding Status: Late Stage Venture
Technology Stack
BioStable actively uses 17 products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Health Diagnostics, Medical Device
Headquarters: Austin, Texas, United States